LIFESTANCE HEALTH GROUP INC (LFST) Stock Analyst Ratings
NASDAQ:LFST - Nasdaq - US53228F1012 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 80% to LFST. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.98. This target is 16.57% above the current price.
LFST was analyzed by 13 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about LFST.
In the previous month the buy percentage consensus was at a similar level.
LFST was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-16 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2024-11-11 | Barclays | Maintains | Underweight -> Underweight |
| 2024-08-15 | UBS | Maintains | Neutral -> Neutral |
| 2024-08-09 | Barclays | Maintains | Underweight -> Underweight |
| 2024-04-22 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2024-03-06 | Jefferies | Maintains | Buy -> Buy |
| 2024-03-04 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-02-29 | Barclays | Maintains | Underweight -> Underweight |
| 2023-11-22 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-11-17 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-08-10 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-07-13 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-05-19 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-05-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-01-06 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2022-11-15 | Goldman Sachs | Maintains | Neutral |
| 2022-11-14 | Cowen & Co. | Maintains | Outperform |
| 2022-08-22 | Cowen & Co. | Maintains | Outperform |
| 2022-05-10 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-12-17 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-11-09 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2021-09-10 | Cowen & Co. | Initiate | Outperform |
| 2021-08-16 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2021-07-06 | William Blair | Initiate | Outperform |
| 2021-07-06 | UBS | Initiate | Buy |
| 2021-07-06 | JP Morgan | Initiate | Overweight |
| 2021-07-06 | Goldman Sachs | Initiate | Neutral |
| 2021-07-06 | Morgan Stanley | Initiate | Overweight |